A role for MHBst167/HBx in hepatitis B virus-induced renal tubular cell apoptosis

Nephrology Dialysis Transplantation

Volumn 25, Issue 7, 2010, Pages 2125-2133

  Hong, Liu ^a   Zhang, Jing ^a   Min, Jie ^a   Lu, Jianrong ^a   Li, Fanfan ^a   Li, Hang ^a   Guo, Shuangping ^a   Li, Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; HBx; MHBst167; NF B; renal tubular cells

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; HEPATITIS B ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PYRROLIDINE DITHIOCARBAMATE; HEPATITIS B VIRUS X PROTEIN; MIDDLE ENVELOPE PROTEIN, HEPATITIS B VIRUS; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; DUAL LUCIFERASE REPORTER ASSAY; ENZYME ACTIVATION; ENZYME ASSAY; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNODETECTION; INCUBATION TIME; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; NICK END LABELING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; CELL LINE; GENETICS; KIDNEY TUBULE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

APOPTOSIS; CELL LINE; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEPATITIS B VIRUS; HUMANS; KIDNEY TUBULES; NF-KAPPA B; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

EID: 77954344347     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp737     Document Type: Article

References (33)

1. Xu H, Sun L, Zhou LJet al. The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritis. Pediatr Nephrol 2003; 18: 1216-1219
2. Takekoshi Y, Tochimaru H, Nagata Y et al. Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int 1991; 35: S34-S39
3. He XY, Fang LJ, Zhang YE et al. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998; 12: 117-120
4. Lai KN, Ho RT, Tam JS et al. Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis. Kidney Int 1996; 50: 1965-1977
5. Ohno H, Kaneko S, Lin Y et al. Human hepatitis B virus X protein augments the DNA binding of nuclear factor for IL-6 through its ba-sic-leucine zipper domain. J Med Virol 1999; 58: 11-18
6. Kekule AS, Lauer U, Meyer M et al. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990; 343: 457-461
7. Lauer U, Weiss L, Hofschneider PH et al. The hepatitis B virus pre-S/S(t) transactivator is generated by 3′ truncations within a defined region of the S gene. J Virol 1992; 66: 5284-5289
8. Doria M, Klein N, Lucito R et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. Embo J 1995; 14: 4747-4757
9. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991; 252: 842-844
10. Meyer M, Caselmann WH, Schluter Vet al. Hepatitis B virus trans-activator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. Embo J 1992; 11: 2991-3001
11. Um HR, Lim WC, Chae SYet al. Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells. Virus Res 2007; 125: 1-8
12. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001; 21: 7721-7730
13. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994; 91: 10350-10354
14. Hildt E, Munz B, Saher G et al. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. Embo J 2002; 21: 525-535
15. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071
16. Henkel T, Machleidt T, Alkalay I et al. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993; 365: 182-185
17. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3: 221-227
18. Ortiz A, Justo P, Sanz A et al. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther 2005; 10: 185-190
19. Nestoridi E, Kushak RI, Duguerre D et al. Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int 2005; 67: 2254-2266
20. Yu Y, Wang HM, Zhang J et al. Expression of NF-kappaB/IkappaB signal pathway in renal tissues of hepatitis B virus-associated nephritis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2006; 22: 327-329
21. Bhimma R, Coovadia HM, Kramvis A et al. HBV and proteinuria in relatives and contacts of children with hepatitis B virus-associated membranous nephropathy. Kidney Int 1999; 55: 2440-2449
22. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663-676
23. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004; 24: 198-211
24. Venkataseshan VS, Lieberman K, Kim DU et al. Hepatitis-B-associ-ated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine (Baltimore) 1990; 69: 200-216
25. Caselmann WH. Trans-activation of cellular genes by hepatitis B virus proteins: a possible mechanism of hepatocarcinogenesis. Adv Virus Res 1996; 47: 253-302
26. Hildt E, Urban S, Hofschneider PH. Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene 1995; 11: 2055-2066
27. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-663
28. Ten RM, Paya CV, Israel N et al. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. Embo J 1992; 11: 195-203
29. Deng CL, Song XW, Liang HJ et al. Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells. World J Gas-troenterol 2006; 12: 1752-1756
30. Huang H, Ma C, Yang M et al. Adrenomedullin impairs the profibro-tic effects of transforming growth factor-beta1 through recruiting Smad6 protein in human renal tubular cells. Cell Physiol Biochem 2005; 15: 117-124
31. Hneino M, Bouazza L, Bricca G et al. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition. J Vasc Res 2009; 46: 85-97
32. Bar J, Cohen-Noyman E, Geiger B et al. Attenuation of the p53 response to DNA damage by high cell density. Oncogene 2004; 23: 2128-2137
33. Bessho R, Matsubara K, Kubota M et al. Pyrrolidine dithiocarba-mate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol 1994; 48: 1883-1889